Replies to post #818323 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Fantastic paper! Seminole work. I have argued over the years that the DCVax-L work up to this point was not yet Nobel worthy, but assuming this research paper is validated and DCVax-L continues to develop as a major potential cancer treatment, the theoretical and practical implications together, from this paper, to me, seem potentially Nobel worthy, eventually. The Nobel committee is very slow in recognizing people and this will take a while to fully validate. Fantastic research!

[exwannabe]

The paper says nothing at all about DC vaccines, or any vaccines. That is just AI generated content based on the "garbage in" AC fed it.

The paper discusses how a better genetic understanding of the GBM lineage allows for proper combination drugs to be selected. Then goes on to describe experiments with a combination of OTX008 (a LGALS1 inhibitor) and Abeaciclib (a CDK4/6 inhibitor) that the analysis predicted should be effective.

This is the exact opposite of -L is.

But whatever. Since this board is willing to believe LSE nonsense and fake SEC quotes that are easy to see are garrbage, I am sure they will believe any AI generated garbage AC feeds them.

But for those who need to supplement with AI, try asking gemini the following question in a clean chat (always start by cllcking the "new chat" button so your old content is not treated as input).

Based on https://www.biorxiv.org/content/10.64898/2026.02.21.707071v1.full.pdf, what would be a good treatment for GBM?

It is amazing none of that DCVax-L reply